On Friday, Standard BioTools Inc (NASDAQ: LAB) was -0.79% down from the session before settling in for the closing price of $2.54. A 52-week range for LAB has been $1.46 – $3.16.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales slid by -0.06% over the last five years. When this article was written, the company’s average yearly earnings per share was at 62.14%. With a float of $369.48 million, this company’s outstanding shares have now reached $383.05 million.
The firm has a total of 539 workers. Let’s measure their productivity.
Standard BioTools Inc (LAB) Insider Activity
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Standard BioTools Inc stocks. The insider ownership of Standard BioTools Inc is 3.54%, while institutional ownership is 54.08%. The most recent insider transaction that took place on Mar 05 ’24, was worth 3,669. In this transaction Director of this company bought 1,403 shares at a rate of $2.62, taking the stock ownership to the 11,497,928 shares. Before that another transaction happened on Mar 04 ’24, when Company’s Director bought 250,000 for $2.57, making the entire transaction worth $642,500. This insider now owns 11,496,525 shares in total.
Standard BioTools Inc (LAB) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of 112.15 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 62.14% per share during the next fiscal year.
Standard BioTools Inc (NASDAQ: LAB) Trading Performance Indicators
You can see what Standard BioTools Inc (LAB) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 1.26. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 9.08.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.94, a number that is poised to hit -0.11 in the next quarter and is forecasted to reach -0.18 in one year’s time.
Technical Analysis of Standard BioTools Inc (LAB)
Analysing the last 5-days average volume posted by the [Standard BioTools Inc, LAB], we can find that recorded value of 2.83 million was better than the volume posted last year of 2.18 million. As of the previous 9 days, the stock’s Stochastic %D was 6.04%. Additionally, its Average True Range was 0.16.
During the past 100 days, Standard BioTools Inc’s (LAB) raw stochastic average was set at 60.15%, which indicates a significant increase from 7.14% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 42.12% in the past 14 days, which was lower than the 62.82% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.59, while its 200-day Moving Average is $2.42. Now, the first resistance to watch is $2.59. This is followed by the second major resistance level at $2.65. The third major resistance level sits at $2.71. If the price goes on to break the first support level at $2.47, it is likely to go to the next support level at $2.41. Should the price break the second support level, the third support level stands at $2.35.
Standard BioTools Inc (NASDAQ: LAB) Key Stats
There are 290,118K outstanding shares of the company, which has a market capitalization of 965.29 million. As of now, sales total 106,340 K while income totals -74,660 K. Its latest quarter income was 28,190 K while its last quarter net income were -19,780 K.
